TCDA

Exchange: NASDAQSector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic

Did you know?

Capital expenditures decreased by 94% from FY20 to FY21.

Current Price

$0.11

Profile

Valuation (TTM)

Market Cap$6.27M

P/E-0.05

EV—

P/B28.75

Shares Out58.03M

P/Sales—

Revenue$0.00

EV/EBITDA—

TCDA (TCDA) Valuation

TCDA Valuation Metrics

FCF$-140.16M

FCF Growth Rate—

EPS Growth (CAGR)—

WACC10.00%

Fair Value Models

Graham Number, PEG-based, and Earnings-based models

View Fair Value →

TCDA Valuation & Fair Value Analysis

TCDA (TCDA) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.

The price-to-earnings (P/E) ratio is -0.05. Price-to-book ratio is 28.75. PEG ratio is 0.00.

GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of TCDA's intrinsic value.